Elderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial

被引：0
|
作者：
Le Tourneau, C. [1 ]
Calugaru, V. [1 ]
Moreno, V. [2 ]
Mirabel, X. [3 ]
Dodger, B. [2 ]
Calvo, E. [2 ]
Jouffroy, T. [1 ]
Rodriguez, J. [1 ]
Chilles, A. [1 ]
Yemi, M. [1 ]
Hoffmann, C. [1 ]
机构：
[1] Inst Curie, Med Oncol, Paris, France
[2] Fdn Jimenez Diaz, Univ Hosp, Med Oncol Start Madrid FJD, Madrid, Spain
[3] Oscar Lambret Ctr, Med Oncol, Lille, France
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1058P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy for the treatment of frail and/or elderly patients with locally advanced HNSCC: a phase I/II study
    Le Tourneau, C.
    Calugaru, V.
    Borcoman, E.
    Moreno, V.
    Calvo, E.
    Liem, X.
    Salas, S.
    Doger, B.
    Jouffroy, T.
    Mirabel, X.
    Rodriguez, J.
    Chilles, A.
    Bernois, K.
    De Rink, M.
    Baskin-Bey, E.
    Fakhry, N.
    Kam, S. Wong Hee
    Hoffmann, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1142 - 1143
  • [2] NBTXR3 Activated by Radiotherapy in Combination With Nivolumab or Pembrolizumab in Patients With Advanced Cancers: A Phase I Trial
    Shen, C.
    Frakes, J. M.
    Niu, J.
    Rosenberg, A. J.
    Weiss, J.
    Caudell, J. J.
    Jameson, K.
    Said, P.
    Seiwert, T. Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E361 - E362
  • [3] NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Cisplatin-Ineligible Patients With Locally Advanced HNSCC: A Phase I Trial
    Le Tourneau, C.
    Calugaru, V.
    Borcoman, E.
    Moreno, V.
    Calvo, E.
    Liem, X.
    Salas, S.
    Doger, B.
    Choussy, O.
    Lesnik, M.
    Mirabel, X.
    Badois, N.
    Krhili, S.
    Blomkvist, J.
    Fakhry, N.
    Kam, S. Wong Hee
    Hoffmann, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E792 - E792
  • [4] A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck
    Caponigro, Francesco
    Romano, Carmen
    Milano, Amalia
    Solla, Raffaele
    Franchin, Giovanni
    Adamo, Vincenzo
    Mari, Ettore
    Morrica, Brunello
    Pepe, Stefano
    [J]. ANTI-CANCER DRUGS, 2008, 19 (07) : 739 - 744
  • [5] A phase 1 trial of NBTXR3 nanoparticles activated by intensity-modulated radiation therapy (IMRT) in the treatment of advanced-stage head and neck squamous cell carcinoma (HNSCC).
    Le Tourneau, Christophe
    Calugaru, Valentin
    Jouffroy, Thomas
    Rodriguez, Jose
    Hoffmann, Caroline
    Dodger, Bernard
    Moreno, Victor
    Calvo, Emiliano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] NBTXR3 activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients
    Le Tourneau, C.
    Calugaru, V.
    Takacsi-Nagy, Z.
    Liem, X.
    Papai, Z.
    Moreno, V.
    Brana, I.
    Salas, S.
    Poissonnet, G.
    Calvo, E.
    Doger, B.
    Choussy, O.
    Mirabel, X.
    Krhili, S.
    Bernois, K.
    Fakhry, N.
    Kam, S. Wong Hee
    Borcoman, E.
    Hoffmann, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S399 - S399
  • [7] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase I/II trial
    Bonomo, P.
    Desideri, I.
    Mangoni, M.
    Loi, M.
    Saieva, C.
    Marrazzo, L.
    Talamonti, C.
    Salvatore, G.
    Sottili, M.
    Teriaca, M. A.
    Stocchi, G.
    Cerbai, C.
    Salvestrini, V.
    Ganovelli, M.
    Massi, D.
    Gallo, O.
    Santoro, R.
    Spinelli, G.
    Pallotta, S.
    Livi, L.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S686 - S686
  • [8] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial
    Le Tourneau, C.
    Takacsi-Nagy, Z.
    Finzi, L.
    Liem, X.
    Calugaru, V.
    Moreno, V.
    Calvo, E.
    Salas, S.
    Doger, B.
    Dubray-Vautrin, A.
    Mirabel, X.
    Badois, N.
    Chilles, A.
    Fakhry, N.
    Kam, S. Wong Hee
    Houdas, L.
    Debard, A.
    Vivar, O. I.
    Farber, L. A.
    Lesnik, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S99 - S99
  • [9] Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients
    Le Tourneau, C.
    Calugaru, V.
    Takacsi-Nagy, Z.
    Liem, X.
    Papai, Z.
    Fijuth, J.
    Garcia, V. Moreno
    Garcia, I. Brana
    Salas, S.
    Poissonnet, G.
    Calvo, E.
    Doger, B.
    Choussy, O.
    Mirabel, X.
    Krhili, S.
    Bernois, K.
    Fakhry, N.
    Kam, S. Wong Hee
    Borcoman, E.
    Hoffmann, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E392 - E392
  • [10] A phase I trial evaluating NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with advanced cancers.
    Shen, Colette
    Frakes, Jessica M.
    Niu, Jiaxin
    Rosenberg, Ari
    Weiss, Jared
    Caudell, Jimmy J.
    Jameson, Katherine LaRoque
    Said, Patricia
    Seiwert, Tanguy Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345